Detailed introduction to how long a box of Sotolaxib (AMG 510) can be taken

Sotorasib (trade name AMG 510) is a KRAS G12C inhibitor, mainly used to treat patients with non-small cell lung cancer (NSCLC) carrying KRAS G12C mutations. The standard recommended dose is 960 mg once a day, usually 8 tablets taken orally at the same time. Since the drug is administered in a fixed dose, how long a box of the drug can be taken depends mainly on the manufacturer's packaging specifications and the patient's daily dose.

In a common market strength, sotoracibutol is sold as 120 mg tablets. A box of medicine generally contains 120 tablets, which means the total dose is 14400mg. If calculated based on the standard daily dosage of 960 mg, which is equivalent to requiring 8 tablets of medicine, one box of medicine can be taken by patients for about 15 days. In other words, if a patient wants to complete a complete 30-day treatment course, he usually needs to prepare two boxes of medicines.

However, it should be noted that the dose of sotoraxib may be adjusted in clinical practice due to patient tolerance, side effects, or comorbid diseases. For example, some patients will reduce the dosage to 720 mg or 480 mg per day according to the doctor's recommendation, which will extend the duration of drug use accordingly. For example, if the dosage is reduced to 720mg/days, one box of medicine can last for about 20days; if it is reduced to 480mg/days, one box can last about 30days. Therefore, the specific medication cycle still needs to be determined based on the patient's personal situation and the attending physician's adjustment plan.

Generally speaking, the cost of treatment with sotorasib is relatively high. Before starting the medication, patients should learn in detail about the actual duration of use corresponding to the specifications and dosage of the medication, and prepare the medication in advance to avoid interrupting treatment. At the same time, it is recommended that patients follow the doctor's guidance and take medications regularly, and conduct regular reviews to monitor efficacy and adverse reactions to ensure that the drugs exert the best anti-cancer effect.

Reference link:https://www.drugs.com